Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain

Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain

Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult population. Current United States and Canadian Chronic non-cancer pain guidelines recommend careful reassessment of the risk-benefit ratio for doses greater than 90 mg morphine equivalent dose (MED), due to low eviden...

Full description

Bibliographic Details
Main Authors: Caroline A. MacCallum, Lauren Eadie, Alasdair M. Barr, Michael Boivin, Shaohua Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
harm reduction
opioid substitution
chronic pain
clinical tool
medical cannabis
morphine equivalent dose (MED)
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.633168/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.633168/full

Similar Items